Document is current
Any future updates will be listed below
-
Authors
Spiegelhalder, Kai
Baglioni, Chiara https://orcid.org/0000-0003-3150-7755
Morin, Charles M. https://orcid.org/0000-0002-8649-8895
Nissen, Christoph
Palagini, Laura
Perlis, Michael L.
Scott, Hannah https://orcid.org/0000-0002-0707-8068
Riemann, Dieter https://orcid.org/0000-0002-1968-6220
- License Information
-
More Information
Article History
Accepted: 9 March 2026
First Online: 9 April 2026
Competing interests
: C.M.M. has served on advisory boards for Eisai, Idorsia and Haleon; has received research support from Lallemand Health; and has received royalties from Mapi Research Trust. C.N. has served on advisory boards for Lundbeck and ldorsia. L.P. served as consultant, adviser or CME speaker for Bruno, Fidia, Idorsia, Italfarmaco, Neopharmed gentili, Pfizer, Pharmanutra, Sanofi-Aventis and Viatris. D.R. has received honoraria for speaking engagements from GET.ON Institut für Online Gesundheitstrainings GmbH, Heel and Idorsia; and has received consultancy fees from GAIA.AG, Heel, Idorsia and X-trodes. K.S., C.B., M.L.P. and H.S. declare no competing interests.
